Against Monopoly

I wrote previously on the Troll Tracker case (see Update on Patent Troll Tracker; Troll Tracker Lands Job Fighting Patent Trolls!). This case concerns defamation suits filed against "Troll Tracker," aka Rick Frenkel, by two Texas lawyers, in the aftermath of Frenkel's identity being revealed, after bounties put up by one of the subjects of his criticism, patent attorney Ray Niro. (It's convoluted, but all you need to know is that Frenkel is the good guy here.)

An updated is provided by Dennis Crouch on Patently-O in Troll Tracker Defamation Lawsuit: Trial Underway. As Crouch notes,

Eric Albritton's defamation lawsuit against Rick Frenkel and his former employer Cisco Systems is underway in the Eastern District of Texas. In my opinion, the case is ridiculous. However, it should serve as a reminder that those vehemently against certain types of speech can often shut-down that speech. Frenkel has indicated that he will not revive his troll tracker blog.

Yet another example of how state law and institutions--including defamation law, state courts themselves and the hideous expense they impose and the injunctive remedies available to judges, and the admixture of IP law--chills free speech.

[StephanKinsella.com cross-post; Mises blog cross-post]

How to extract money for using copyrighted performances The New York Times Magazine followed up on its earlier piece about The Copyright Enforcers with

NYTimes finds more IP news but doesn't report its consumer cost Enabling people to set up contests or awards of prizes is what I hope my Contingency Market can

NYTimes finds more IP news but doesn't report its consumer cost A couple of things can be done to encourage phamaceutical development without creating a monopoly.

Comment Posting Announcement Justin Levine's post has comments disabled again: Paul Allen Files Patent Lawsuits Against The

Germany Not many comments on that article. I presume that means it has a tiny audience. Oh well, I guess

NYTimes finds more IP news but doesn't report its consumer cost To start with, shift the cost burden of later-stage clinical trials to the FDA and

NYTimes finds more IP news but doesn't report its consumer cost If I may ask a very simple question. What would you do to encourage the "invention" of new and

Free textbooks If you are unable to get free textbooks but need cheap college books, I recommend visiting

Comment Posting Announcement Lewis Hyde's Justin Levine has disabled

Against Monopoly

defending the right to innovate

Patent Law, State Courts, and Free Speech: The Case of Troll Tracker

Comments

Submit Comment